Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
morphine + tetracaine
- Development stage
- Phase 3
- Modality
- Small Molecules
- Administration
- Topical, Intravenous
01
Overview
Morphine + tetracaine is a combination drug used for pain management. Morphine is an opioid agonist that acts on the central nervous system to relieve moderate to severe pain, while tetracaine (amethocaine) is a local anesthetic that provides topical analgesia. This combination has been studied for use in procedures such as central line placement in ventilated neonates, where it was found to provide superior analgesia compared to tetracaine alone.
- Other names
- morphine + amethocaine
02
Targets
DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on morphine + tetracaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on morphine + tetracaine.